Lantheus (LNTH) Grants AHN Exclusive Rights for Use of Microbubbles in Combination with Ultrasound Assisted Gene Therapy for Development of Proposed Treatment for Xerostomia
Go back to Lantheus (LNTH) Grants AHN Exclusive Rights for Use of Microbubbles in Combination with Ultrasound Assisted Gene Therapy for Development of Proposed Treatment for Xerostomia| (NASDAQ: LNTH) | Delayed: 106.20 +2.34 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.86 | 52 Week High | $10.70 | |||
| Open | $104.47 | 52 Week Low | $1.76 | |||
| Day High | $106.63 | P/E | N/A | |||
| Day Low | $103.49 | EPS | $0.00 | |||
| Volume | 630,400 | |||||
